Binnaz Staley is a highly experienced scientist in the fields of cancer biology and immunotherapy, currently serving as a Senior Principal Scientist at Amgen since July 2023, after previously holding the position of Principal Scientist at Amgen from February 2022. Staley's professional journey includes significant roles such as Principal Scientist at Bristol Myers Squibb and Senior Scientist II at AbbVie, with a focus on immuno-oncology. Earlier experience includes a Postdoctoral Fellowship at UCSF, where research involved studying signaling pathways related to pancreatic cancer, and a Research Scientist position at Eureka Therapeutics, Inc. Education includes a Ph.D. in Developmental Biology from Rutgers University and postdoctoral training at UCSF. Early formative experiences include internships at Weill Cornell Medical College and EMBL, where Staley gained proficiency in molecular cloning techniques and cancer cell lines.
This person is not in the org chart
This person is not in any teams
This person is not in any offices